ContextVision (CONTX.OL) Osake Kurssi

ContextVision AB is primarily active in the medical imaging industry.

The main competitors of ContextVision AB in the market include companies such as GE Healthcare, Siemens Healthineers, and Merge Healthcare. These companies also operate in the medical imaging and artificial intelligence software sectors, offering similar products and solutions. ContextVision AB strives to distinguish itself through its innovative technologies and advanced image enhancement solutions, ensuring enhanced image quality and accurate diagnoses for healthcare professionals. With a strong focus on research and development, ContextVision AB continuously aims to stay ahead of the competition and deliver cutting-edge software solutions to meet the evolving needs of the medical imaging industry.

ContextVision AB is a renowned company specializing in medical imaging software solutions. Established in 1983, the company has amassed a rich history and background in the medical technology domain. ContextVision AB focuses on developing innovative software, such as image enhancement, 3D visualization, and AI-based technologies, catering to healthcare providers and medical imaging equipment manufacturers globally. With its strong industry expertise and continuous research and development efforts, ContextVision AB has positioned itself as a leading provider of state-of-the-art imaging solutions. The company's dedication to quality and customer satisfaction has earned it a reputable name in the medical imaging industry.

ContextVision AB has successfully achieved several significant milestones over the years. Some noteworthy accomplishments include developing innovative software solutions for medical imaging, establishing strong partnerships with leading industry players, and receiving numerous prestigious awards for their cutting-edge technologies. Additionally, ContextVision AB has consistently demonstrated strong financial performance and growth, consolidating its position as a key player in the medical imaging market. These milestones highlight the company's commitment to innovation, excellence, and delivering value to its customers. ContextVision AB's achievements emphasize its reputation as a reliable and forward-thinking company in the field of medical imaging.

ContextVision AB is primarily present in several countries and regions. It has a strong presence in Europe, with a focus on Scandinavian countries such as Sweden, Norway, and Finland. The company also operates in other European regions including Germany and the United Kingdom. In addition to Europe, ContextVision AB has expanded its presence in the Asia-Pacific region, particularly in China and Japan. Furthermore, the company has a growing customer base in North America, particularly in the United States and Canada. ContextVision AB's global footprint allows it to cater to a wide range of customers and provide its innovative stock services worldwide.

ContextVision AB represents a strong set of values and corporate philosophy. The company is committed to delivering high-quality medical imaging software solutions to healthcare providers worldwide. ContextVision AB prioritizes innovation, collaboration, and customer satisfaction. With a strong focus on research and development, ContextVision AB continuously strives to enhance patient care and improve outcomes. By leveraging cutting-edge technology and expertise, the company aims to provide efficient and reliable solutions for medical image analysis and enhancement. ContextVision AB's commitment to excellence and customer-centric approach make it a trusted leader in the healthcare technology industry.

Analyytikot asettavat tällä hetkellä ContextVision-osakkeelle keskimääräisen tavoitehinnan 4,26 SEK (mediaani: 4,26 SEK), mikä merkitsee −23,0 % viimeisimpään hintaan verrattuna. Konsensus perustuu 7 analyytikkoarvioon.

ContextVision Analyytikkojen kursstavoitteet 2026

7 analyytikkoa arvioi tällä hetkellä ContextVision-osaketta: 0 suosittaa ostoa, 3 pitoa ja 4 myyntiä. Vuodelle 2026 analyytikot odottavat ContextVision-yhtiöltä 105,61 M SEK liikevaihtoa ja 0,15 SEK osakekohtaista tulosta.

ContextVision Analyytikkojen kursstavoitteet 2026

Nykyisellä valuuttakurssilla ContextVision-osake noteerataan hintaan 0,49 EUR (5,53 SEK).

ContextVision-osake (CONTX.OL) on listattuna 3 pörssissä, muun muassa: London (0L8Z.L), Oslo (CONTX.OL).

ContextVision AB is a leading provider of innovative solutions in the field of medical imaging. The company was founded in 1983 and currently employs over 100 employees. It has been listed on the Nasdaq Stockholm since 1999 and is headquartered in Stockholm, Sweden. ContextVision consists of four business areas that focus on specific segments of medical imaging: digital pathology, ultrasound, mammography, and radiography. Each business area offers a wide range of products and services aimed at improving precision, efficiency, and patient care. The product portfolio of ContextVision is tailored to the needs of medical professionals and clinicians who rely on accurate analysis and diagnosis of images. For example, the company offers a state-of-the-art software platform for digital pathology, allowing pathologists to digitally capture, store, and analyze histological images and data. This improves the accuracy of diagnosis and increases efficiency in pathology laboratories. Another example is the company's ultrasound division, which focuses on improving image quality and precision in ultrasound diagnostics. Through its image enhancement technology, ContextVision provides more productive diagnostic solutions that are faster and more accurate than conventional ultrasound systems. The company also offers solutions for mammography that target the detection of smaller tumors. Together, these offerings not only improve patient care but also contribute to reducing medical errors. ContextVision gains market share through partnerships with leading manufacturers of medical imaging devices. The company leverages its unique expertise in image analysis and enhancement to develop innovative solutions in collaboration with its partners. This collaboration has, for example, led to the development of the "GOPiCE" concept, which represents a benchmark in digital pathology. The range of solutions allows customers to create more efficient diagnoses while ensuring higher accuracy and reliability in patient care. Overall, ContextVision has secured its leading position in the field of medical imaging through the continuity of its performance and its willingness to adapt to the needs of its customers and partners. The company is committed to improving medical imaging and supporting its customers through innovative solutions. ContextVision is a pioneer in image analysis and an important component in the medical field.

odotettu liikevaihto ContextVision on 105,61 M SEK. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.

odotettu voitto ContextVision on 11,28 M SEK. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.

ContextVision:n hinta-voitto-suhde (P/E) on tällä hetkellä 37,17. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan ContextVision-osakkeen arvostusta.

ContextVision:n hinta-myynti-suhde (P/S) on tällä hetkellä 3,97. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii ContextVision-osakkeen arvostuskennuslukuna.

ContextVision:n Eulpool-laatuscore on 1/10.

ContextVision:n ISIN on SE0014731154. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

ContextVision:n WKN on A2QA6S. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

ContextVision:n ticker on CONTX.OL. Tämä pörssinoteeraus käytetään ContextVision-osakkeiden kauppaan pörssissä.